S Seton-Rogers - Nature Reviews Cancer, 2011 - nature.com Although the prevailing hypothesis has been that high-grade serous ovarian carcinoma (HGSOC) arises from ovarian surface epithelial cells, recent evidence suggests that around 50% of these tumours arise from fallopian tube secretory epithelial cells (FTSECs). ... All 3 versions
U Chandavarkar, M Campan… - GYNECOL …, 2011 - discovery.ucl.ac.uk ... DNA methylation markers associated with serous ovariancancer subtypes. ... 10.1016/j.ygyno. 2010.12.117. Full text not available from this repository. Type: Article. Title: DNA methylation markers associated with serous ovariancancer subtypes. DOI: 10.1016/j.ygyno.2010.12.117. ... Cached - All 2 versions
DW Cramer, RC Bast, CD Berg, EP Diamandis… - Cancer Prevention …, 2011 - AACR Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis. We used specimens from the ... Cited by 13 - Related articles - All 4 versions
IA Silva, S Bai, K McLean, K Yang, K Griffith… - Cancer Research, 2011 - AACR Markers that reliably identify cancer stem cells (CSC) in ovarian cancer could assist prognosis and improve strategies for therapy. CD133 is a reported marker of ovarian CSC. Aldehyde dehydrogenase (ALDH) activity is a reported CSC marker in several solid tumors, but it has not been ... Cited by 3 - Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
